Immune check points in cancer treatment: current challenges and perspectives

Br J Cancer. 2023 Oct;129(9):1365-1366. doi: 10.1038/s41416-023-02478-6.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Neoplasms*
  • Programmed Cell Death 1 Receptor

Substances

  • Programmed Cell Death 1 Receptor